HOME › DRUGS › OBINUTUZUMAB
ACTIVE SUBSTANCE / INN

OBINUTUZUMAB

Brand name(s): Gazyvaro, GAZYVA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Leukemia, Lymphocytic, Chronic, B-Cell
BLA125486
ACTIVE SUBSTANCE
Obinutuzumab
REGULATORS
FDA · EMA
SPONSORS / MAH
GENENTECH, Roche Registration GmbH
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GAZYVABLA125486GENENTECHPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
GazyvaroRoche Registration GmbHAuthorised22/07/2014Leukemia, Lymphocytic, Chronic, B-Cell

FULL INTELLIGENCE ON OBINUTUZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →